
Cynthia M. Fogg
Examiner (ID: 15689, Phone: (571)272-2741 , Office: P/2427 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2421, 2427 |
| Total Applications | 531 |
| Issued Applications | 391 |
| Pending Applications | 52 |
| Abandoned Applications | 100 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3558968
[patent_doc_number] => 05500418
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-19
[patent_title] => 'Aminoalkanephosphinic acids and salts thereof'
[patent_app_type] => 1
[patent_app_number] => 8/308040
[patent_app_country] => US
[patent_app_date] => 1994-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10153
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/500/05500418.pdf
[firstpage_image] =>[orig_patent_app_number] => 308040
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/308040 | Aminoalkanephosphinic acids and salts thereof | Sep 15, 1994 | Issued |
Array
(
[id] => 3591844
[patent_doc_number] => 05585504
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'Process of making cox-2 inhibitors having a lactone bridge'
[patent_app_type] => 1
[patent_app_number] => 8/307972
[patent_app_country] => US
[patent_app_date] => 1994-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5915
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585504.pdf
[firstpage_image] =>[orig_patent_app_number] => 307972
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/307972 | Process of making cox-2 inhibitors having a lactone bridge | Sep 15, 1994 | Issued |
Array
(
[id] => 3633417
[patent_doc_number] => 05610122
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => '3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/303987
[patent_app_country] => US
[patent_app_date] => 1994-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33105
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 370
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610122.pdf
[firstpage_image] =>[orig_patent_app_number] => 303987
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/303987 | 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives | Sep 8, 1994 | Issued |
Array
(
[id] => 3590346
[patent_doc_number] => 05496834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-03-05
[patent_title] => 'Lactol derivatives, their production and use'
[patent_app_type] => 1
[patent_app_number] => 8/300738
[patent_app_country] => US
[patent_app_date] => 1994-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19918
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/496/05496834.pdf
[firstpage_image] =>[orig_patent_app_number] => 300738
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/300738 | Lactol derivatives, their production and use | Sep 1, 1994 | Issued |
Array
(
[id] => 3463742
[patent_doc_number] => 05468855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'Bislactones'
[patent_app_type] => 1
[patent_app_number] => 8/298899
[patent_app_country] => US
[patent_app_date] => 1994-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4371
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468855.pdf
[firstpage_image] =>[orig_patent_app_number] => 298899
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/298899 | Bislactones | Aug 30, 1994 | Issued |
Array
(
[id] => 4185077
[patent_doc_number] => 06150402
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Natriuretic compounds'
[patent_app_type] => 1
[patent_app_number] => 8/290430
[patent_app_country] => US
[patent_app_date] => 1994-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 13332
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150402.pdf
[firstpage_image] =>[orig_patent_app_number] => 290430
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/290430 | Natriuretic compounds | Aug 14, 1994 | Issued |
Array
(
[id] => 3453678
[patent_doc_number] => 05451578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-09-19
[patent_title] => 'Fibrinogen receptor antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/289974
[patent_app_country] => US
[patent_app_date] => 1994-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13493
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/451/05451578.pdf
[firstpage_image] =>[orig_patent_app_number] => 289974
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/289974 | Fibrinogen receptor antagonists | Aug 11, 1994 | Issued |
Array
(
[id] => 3520128
[patent_doc_number] => 05530022
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-25
[patent_title] => 'Esters of 2,2-dimethyl-3-(3,3,3-trifluoro-1-propenyl)-cyclopropane carboxylic acid'
[patent_app_type] => 1
[patent_app_number] => 8/287839
[patent_app_country] => US
[patent_app_date] => 1994-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3464
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/530/05530022.pdf
[firstpage_image] =>[orig_patent_app_number] => 287839
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/287839 | Esters of 2,2-dimethyl-3-(3,3,3-trifluoro-1-propenyl)-cyclopropane carboxylic acid | Aug 8, 1994 | Issued |
Array
(
[id] => 3649088
[patent_doc_number] => 05637736
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Process for preparing 1-bromoalkylbenzene derivatives and intermediates thereof'
[patent_app_type] => 1
[patent_app_number] => 8/286411
[patent_app_country] => US
[patent_app_date] => 1994-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7274
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637736.pdf
[firstpage_image] =>[orig_patent_app_number] => 286411
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/286411 | Process for preparing 1-bromoalkylbenzene derivatives and intermediates thereof | Aug 4, 1994 | Issued |
Array
(
[id] => 3524291
[patent_doc_number] => 05489697
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-02-06
[patent_title] => 'Method for the preparation of (+)-calanolide A and intermediates thereof'
[patent_app_type] => 1
[patent_app_number] => 8/285655
[patent_app_country] => US
[patent_app_date] => 1994-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5220
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/489/05489697.pdf
[firstpage_image] =>[orig_patent_app_number] => 285655
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/285655 | Method for the preparation of (+)-calanolide A and intermediates thereof | Aug 2, 1994 | Issued |
Array
(
[id] => 3688879
[patent_doc_number] => 05696159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Lactone compounds for treating patients with precancerous lesions'
[patent_app_type] => 1
[patent_app_number] => 8/265396
[patent_app_country] => US
[patent_app_date] => 1994-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13688
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/696/05696159.pdf
[firstpage_image] =>[orig_patent_app_number] => 265396
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/265396 | Lactone compounds for treating patients with precancerous lesions | Aug 2, 1994 | Issued |
Array
(
[id] => 3526867
[patent_doc_number] => 05527916
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-18
[patent_title] => 'Pyranones'
[patent_app_type] => 1
[patent_app_number] => 8/211043
[patent_app_country] => US
[patent_app_date] => 1994-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9064
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 350
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/527/05527916.pdf
[firstpage_image] =>[orig_patent_app_number] => 211043
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/211043 | Pyranones | Jul 31, 1994 | Issued |
| 08/278882 | NONPEPTIDE ENDOTHELIN ANTAGONISTS I | Jul 25, 1994 | Abandoned |
Array
(
[id] => 3483265
[patent_doc_number] => 05457245
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-10
[patent_title] => 'Process for preparation of calcitriol lactone and related intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/273387
[patent_app_country] => US
[patent_app_date] => 1994-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2874
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/457/05457245.pdf
[firstpage_image] =>[orig_patent_app_number] => 273387
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/273387 | Process for preparation of calcitriol lactone and related intermediates | Jul 10, 1994 | Issued |
Array
(
[id] => 3691325
[patent_doc_number] => 05604182
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-18
[patent_title] => 'Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses'
[patent_app_type] => 1
[patent_app_number] => 8/273240
[patent_app_country] => US
[patent_app_date] => 1994-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19760
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/604/05604182.pdf
[firstpage_image] =>[orig_patent_app_number] => 273240
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/273240 | Milbemycin ether derivatives, their preparation and their therapeutic and agrochemical uses | Jul 10, 1994 | Issued |
| 08/266561 | METHOD FOR THE PREPARATION OF A NOVEL C-RING PRECURSOR FOR TAXOIDS AND NOVEL INTERMEDIATES | Jun 27, 1994 | Abandoned |
Array
(
[id] => 3628128
[patent_doc_number] => 05621120
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Process for the manufacture of form 1 ranitidine hydrochloride'
[patent_app_type] => 1
[patent_app_number] => 8/265307
[patent_app_country] => US
[patent_app_date] => 1994-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2427
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621120.pdf
[firstpage_image] =>[orig_patent_app_number] => 265307
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/265307 | Process for the manufacture of form 1 ranitidine hydrochloride | Jun 23, 1994 | Issued |
Array
(
[id] => 3473259
[patent_doc_number] => 05476874
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-19
[patent_title] => 'New HIV protease inhibitors'
[patent_app_type] => 1
[patent_app_number] => 8/263621
[patent_app_country] => US
[patent_app_date] => 1994-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7608
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/476/05476874.pdf
[firstpage_image] =>[orig_patent_app_number] => 263621
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/263621 | New HIV protease inhibitors | Jun 21, 1994 | Issued |
Array
(
[id] => 3422045
[patent_doc_number] => 05478951
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-26
[patent_title] => 'Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds'
[patent_app_type] => 1
[patent_app_number] => 8/263967
[patent_app_country] => US
[patent_app_date] => 1994-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1859
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/478/05478951.pdf
[firstpage_image] =>[orig_patent_app_number] => 263967
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/263967 | Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds | Jun 21, 1994 | Issued |
Array
(
[id] => 3614470
[patent_doc_number] => 05510371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-23
[patent_title] => 'Inhibitors of farnesyl-protein transferase'
[patent_app_type] => 1
[patent_app_number] => 8/254228
[patent_app_country] => US
[patent_app_date] => 1994-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8711
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/510/05510371.pdf
[firstpage_image] =>[orig_patent_app_number] => 254228
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/254228 | Inhibitors of farnesyl-protein transferase | Jun 5, 1994 | Issued |